Name: 북미 암 침 검사 장비 시장 – 2028년까지의 산업 동향 및 예측
Brand: Data Bridge Market Research
SKU: 64146
Price: 3500.00 USD
Availability: InStock
Rating: 4.5 (51 reviews)

>북미 암 침 검사 장치 시장, 제품 유형별(침 채취 키트, 체액 특정 장치, 구강 면봉, 바코드 라벨, 침 냉동 보관 상자 및 기타), 채취 부위(하악하선/설하선, 이하선 및 소타액선), 적용 분야(간-폐암, 유방암, 대장 및 직장암, 전립선암, 췌장암, 구강암, 갑상선암, 자궁내막암, 신장암, 백혈병, 흑색종, 비호지킨 림프종 및 기타), 연령대(성인 및 소아과), 채취 방법(수동 침, 구강 면봉 및 기타), 최종 사용자(병원, 진단 실험실, 종양학 전문 병원, 암 연구소 및 기타), 유통 채널(직접 입찰, 소매 판매 및 기타) 국가(미국, 캐나다 및 멕시코) 산업 동향 및 예측 2028년.

시장 분석 및 통찰력: 북미 암 침 검사 장치 시장

북미 암 침 검사 장치 시장은 2021년부터 2028년까지의 예측 기간 동안 상당한 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 북미 암 침 검사 장치 시장이 2021년부터 2028년까지의 예측 기간 동안 10.0%의 CAGR로 성장하고 있으며 2020년 2억 3,006만 달러에서 2028년까지 4억 7,328만 달러에 도달할 것으로 예상한다고 분석했습니다. 만성 질환의 유병률 증가와 암 환자의 증가가 주요 원동력으로, 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

타액 검사는 암 탐지에 광범위하게 사용됩니다. 암 타액은 돌연변이 된 세포외 DNA와 RNA의 존재 또는 부재를 검사합니다. 종양 세포는 DNA와 RNA를 순환계로 방출하고 타액으로 들어오며, 돌연변이는 타액에서 매우 정확하게 탐지할 수 있습니다.

암 타액 검사 장치 시장 은 인간의 약물 , 감염 또는 질병을 탐지하는 데 사용되는 검사 키트, 면봉, 카세트 및 장치로 구성됩니다. 여러 유형의 키트는 질병 탐지를 위해 다양한 유형의 분자 생물학 방법을 활용합니다. ELISA, PCR, 면역 검정 및 효소 검정은 타액 검사에 사용되는 분자 기술입니다.

북미 암 침 검사 장치 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.

북미 암 침 검사 장치 시장 범위 및 시장 규모

North America cancer spit test device market is segmented on the basis of product type, site of collection, application, age group, method of collection, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of product type, the North America cancer spit test devices market is segmented into saliva collection kits, fluid specific devices, oral swab, bar-code labels, saliva cryostorage box, and others. In 2021, saliva collection kits segment is expected to dominate the market due to increasing demand for POCT devices and rising prevalence of cancer patients in the region. .
On the basis of site of collection, the North America cancer spit test devices market is segmented into sub-mandibular/sub-lingual gland, parotid gland, and minor salivary gland. In 2021, sub-mandibular/sub-lingual gland segment is expected to dominate the market owing to surging pool of cancer patients and increasing healthcare expenditure.
On the basis of application, the North America cancer spit test devices market is segmented into liver-lung cancer, breast cancer, colon and rectal cancer, prostate cancer, pancreatic cancer, oral cancer, thyroid cancer, endometrial cancer, kidney cancer, leukemia, melanoma, non-hodgkin lymphoma, and others. In 2021, liver-lung cancer segment is expected to dominate the market because of changing lifestyle and rising incidences of liver cirrhosis.
On the basis of age group, the North America cancer spit test devices market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market because of increasing geriatric population and rising prevalence of chronic diseases in the region.
On the basis of method of collection, the North America cancer spit test devices market is segmented into passive drool, oral swab, and others. In 2021, passive drool segment is expected to dominate the market because it is stored and collected with better patient compliance.
On the basis of end user, the North America cancer spit test devices market is segmented into hospitals, diagnostic laboratories, oncology specialty clinics, cancer research institutes, and others. In 2021, hospitals segment is expected to dominate the market because of growing awareness among people about cancer and its treatment.
On the basis of distribution channel, the North America cancer spit test devices market is segmented into direct tender, retail sales, and others. In 2021, direct sales segment is expected to dominate the market owing to rising healthcare expenditure and easy accessibility of products.

North America Cancer Spit Test Devices Market Country Level Analysis

The North America cancer spit test devices market is analyzed and market size information is provided based on product type, site of collection, application, age group, method of collection, end user, and distribution channel.

Countries covered in the North America cancer spit test device market report are the U.S., Canada, and Mexico. North America is expected to dominate the cancer spit test devices market due to rising prevalence of chronic diseases in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Healthcare Expenditure and High Prevalence of Cancer are Creating New Opportunities for Players in the North America Cancer Spit Test Devices Market

Saliva collection kits segment in the U.S. is expected to grow with the highest rate and is dominating North America region in the forecast period of 2021 to 2028 owing to rising prevalence of cancer in the country.

North America cancer spit test devices market also provides you with detailed market analysis for every country growth in particular industry with the North America cancer spit test device market sales, impact of advancement in the North America cancer spit test device market and changes in regulatory scenarios with their support for the North America cancer spit test devices market. The data is available for historic period 2010 to 2018.

Competitive Landscape and North America Cancer Spit Test Device Market Share Analysis

North America cancer spit test device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus related to North America cancer spit test devices market.

보고서에서 다루는 주요 기업으로는 DNA Genotek, Salimetrics, LLC, PeriRx, Color Health, Inc., SARSTEDT AG. Co. KG, Miraclean Technology Co., Ltd., Agilent Technologies, Inc., Illumina, Inc., QIAGEN, Thermo Fisher Scientific Inc., Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Oasis Diagnostics Corporation, Canvax(dobuss의 자회사) 등이 있으며, 국내 및 북미 기업도 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

또한 전 세계 여러 회사에서 다양한 제품 출시와 계약을 체결하면서 북미 암 침 검사 장치 시장 성장이 더욱 가속화되고 있습니다.

예를 들어,

2021년 1월, DNA Genotek은 미국 식품의약국(FDA)이 OrageneDx 제품군에 대한 일반 사용 510(k) 허가를 내렸다고 발표했습니다. 이 FDA 승인으로 시장에서 회사의 신뢰도가 높아졌고 이 제품에 대한 수요가 증가했습니다.
2021년 2월 Thermo Fisher Scientific은 CMO 리더십 어워드 6개를 수상했습니다. 역량, 호환성, 전문성, 품질, 신뢰성, 서비스를 포함한 6개 부문에서 모두 수상했습니다. Thermo Fisher가 6개 부문에서 모두 수상한 것은 이번이 두 번째 연속이며, 회사가 CMO 리더십 어워드를 수상한 것은 전체적으로 여덟 번째입니다. 이를 통해 회사의 신뢰성이 높아지고 수익 창출에 도움이 되었습니다.

SKU-64146

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Click on image to enlarge

대화형 데이터 분석 대시보드
높은 성장 잠재력 기회를 위한 회사 분석 대시보드
사용자 정의 및 질의를 위한 리서치 분석가 액세스
대화형 대시보드를 통한 경쟁자 분석
최신 뉴스, 업데이트 및 추세 분석
포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용

데모 요청

표 목록

LIST OF TABLES

TABLE 1 NEW CANCER CASES, AGES 85+, IN THE U.S.

TABLE 2 DEATH CAUSES DUE TO CANCER, AGES 85+, IN THE U.S.

TABLE 3 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICE MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA FLUID SPECIFIC DEVICES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA BAR-CODE LABELS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA SALIVA CRYOSTORAGE BOX IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA SUB-MANDIBULAR/SUB-LINGUAL GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA PAROTID GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA MINOR SALIVARY GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA LIVER-LUNG CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA BREAST CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA COLON AND RECTAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA PROSTATE CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA PANCREATIC CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA ORAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA THYROID CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA ENDOMETRIAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA KIDNEY CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA LEUKEMIA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA MELANOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA NON-HODGKIN LYMPHOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA ADULT IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA PEDIATRICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA PASSIVE DROOL IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA HOSPITALS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA DIAGNOSTIC LABORATORIES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA ONCOLOGY SPECIALITY CLINICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA CANCER RESEARCH INSTITUTES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA DIRECT TENDER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 NORTH AMERICA RETAIL SALES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 47 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 50 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 52 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 53 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 54 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 55 U.S. CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 56 U.S. SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 57 U.S. CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 58 U.S. CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 59 U.S. CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 60 U.S. CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 61 U.S. CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 62 U.S. CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 63 CANADA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 64 CANADA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 65 CANADA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 66 CANADA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 CANADA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 68 CANADA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 69 CANADA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 70 CANADA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 MEXICO CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 72 MEXICO SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 73 MEXICO CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 74 MEXICO CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 MEXICO CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 76 MEXICO CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 77 MEXICO CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 78 MEXICO CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

그림 목록

LIST OF FIGURES

FIGURE 1 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : SEGMENTATION

FIGURE 2 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : DATA TRIANGULATION

FIGURE 3 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : DROC ANALYSIS

FIGURE 4 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : MARKET APPLICATION COVERAGE GRID

FIGURE 9 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : SEGMENTATION

FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE NORTH AMERICA CANCER SPIT TEST DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 SALVIA COLLECTION KIT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CANCER SPIT TEST DEVICES MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA CANCER SPIT TEST DEVICES MARKET

FIGURE 14 ESTIMATED NUMBER OF NEW CASES IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES

FIGURE 15 ESTIMATED AGE-STANDARDIZED INCIDENCE RATES (WORLD) IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES

FIGURE 16 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2020

FIGURE 17 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)

FIGURE 18 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, CAGR (2021-2028)

FIGURE 19 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 20 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2020

FIGURE 21 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2021-2028 (USD MILLION)

FIGURE 22 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, CAGR (2021-2028)

FIGURE 23 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, LIFELINE CURVE

FIGURE 24 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2020

FIGURE 25 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 26 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 27 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 28 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2020

FIGURE 29 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2021-2028 (USD MILLION)

FIGURE 30 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, CAGR (2021-2028)

FIGURE 31 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 32 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2020

FIGURE 33 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2021-2028 (USD MILLION)

FIGURE 34 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, CAGR (2021-2028)

FIGURE 35 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, LIFELINE CURVE

FIGURE 36 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, 2020

FIGURE 37 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, 2021-2028 (USD MILLION)

FIGURE 38 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, CAGR (2021-2028)

FIGURE 39 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, LIFELINE CURVE

FIGURE 40 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 41 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 42 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 43 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: SNAPSHOT (2020)

FIGURE 45 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020)

FIGURE 46 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 47 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 48 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY PRODUCT TYPE (2021-2028)

FIGURE 49 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: COMPANY SHARE 2020 (%)

자세한 정보 보기

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.